Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Lactobacillus acidophilus and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice

  • Authors:
    • Xing Lu
    • Fengmei Wang
  • View Affiliations / Copyright

    Affiliations: The Third Central Clinical College, Tianjin Medical University, Tianjin 300170, P.R. China
    Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 1005
    |
    Published online on: July 15, 2021
       https://doi.org/10.3892/etm.2021.10438
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ethanol exposure frequently induces intestinal and liver injury, dysbiosis of the gut microbiota and vitamin C (VC) deficiency. Gut microbiota‑targeted therapy is emerging as an important adjuvant method for protecting the body against ethanol‑induced injury, particularly probiotics containing Lactobacillus acidophilus (LA). However, the feasibility and efficiency of using synbiotics containing LA and VC against ethanol‑induced injury remained largely undetermined. To examine the advantages of LA+VC, their effect was evaluated in an ethanol‑fed mouse model. The results suggested that LA+VC restored gut microbiota homeostasis and reinstated the immune balance of colonic T‑regulatory cells (CD4+CD45+forkhead box p3+). In addition, intestinal barrier disorders were improved via upregulating tight junction proteins (claudin‑2, zona occludens‑1 and occludin) and mucus secretion, which prevented the translocation of lipopolysaccharide into circulatory systems and subsequently reduced the expression of Toll‑like receptor 4 in liver tissues. In this context, LA+VC treatment reduced the inflammatory response in the liver, which was likely responsible for the improved liver function in ethanol‑challenged mice. Collectively, these results indicated that LA+VC treatment significantly protected the intestine and liver from ethanol damage by enhancing intestinal barrier function and reducing systemic inflammation. The present study paved the way for further exploration of synbiotics based on Lactobacillus species and VC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Parry CD, Patra J and Rehm J: Alcohol consumption and non-communicable diseases: Epidemiology and policy implications. Addiction. 106:1718–1724. 2011.PubMed/NCBI View Article : Google Scholar

2 

World Health Organization: Global status report on alcohol and health. Geneva, Switzerland, WHO Press, 2018.

3 

Rusyn I and Bataller R: Alcohol and toxicity. J Hepatol. 59:387–388. 2013.PubMed/NCBI View Article : Google Scholar

4 

Bajaj JS: Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 16:235–246. 2019.PubMed/NCBI View Article : Google Scholar

5 

Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al: Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 5(141)2017.PubMed/NCBI View Article : Google Scholar

6 

Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, et al: Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA. 111:E4485–E4493. 2014.PubMed/NCBI View Article : Google Scholar

7 

Cho YE, Yu LR, Abdelmegeed MA, Yoo SH and Song BJ: Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury. J Hepatol. 69:142–153. 2018.PubMed/NCBI View Article : Google Scholar

8 

Kirpich IA, McClain CJ, Vatsalya V, Schwandt M, Phillips M, Falkner KC, Zhang L, Harwell C, George DT and Umhau JC: Liver injury and endotoxemia in male and female alcohol-dependent individuals admitted to an alcohol treatment program. Alcohol Clin Exp Res. 41:747–757. 2017.PubMed/NCBI View Article : Google Scholar

9 

Pickard JM, Zeng MY, Caruso R and Núñez G: Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 279:70–89. 2017.PubMed/NCBI View Article : Google Scholar

10 

Caruso R, Lo BC and Nunez G: Host-microbiota interactions in inflammatory bowel disease. Nat Rev Immunol. 20:411–426. 2020.PubMed/NCBI View Article : Google Scholar

11 

Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al: Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 167:1469–1480.e12. 2016.PubMed/NCBI View Article : Google Scholar

12 

Fattorusso A, Di Genova L, Dell'Isola GB, Mencaroni E and Esposito S: Autism spectrum disorders and the gut microbiota. Nutrients. 11(521)2019.PubMed/NCBI View Article : Google Scholar

13 

Torres-Fuentes C, Schellekens H, Dinan TG and Cryan JF: The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol. 2:747–756. 2017.PubMed/NCBI View Article : Google Scholar

14 

Bordalo Tonucci L, Dos Santos KM, De Luces Fortes Ferreira CL, Ribeiro SM, De Oliveira LL and Martino HS: Gut microbiota and probiotics: Focus on diabetes mellitus. Crit Rev Food Sci Nutr. 57:2296–2309. 2017.PubMed/NCBI View Article : Google Scholar

15 

Bajaj JS, Kakiyama G, Zhao D, Takei H, Fagan A, Hylemon P, Zhou H, Pandak WM, Nittono H, Fiehn O, et al: Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol Clin Exp Res. 41:1857–1865. 2017.PubMed/NCBI View Article : Google Scholar

16 

Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR, et al: Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 60:940–947. 2014.PubMed/NCBI View Article : Google Scholar

17 

Rao R: Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. 50:638–644. 2009.PubMed/NCBI View Article : Google Scholar

18 

Szabo G and Bala S: Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 16:1321–1329. 2010.PubMed/NCBI View Article : Google Scholar

19 

Mehta G, Macdonald S, Cronberg A, Rosselli M, Khera-Butler T, Sumpter C, Al-Khatib S, Jain A, Maurice J, Charalambous C, et al: Short-term abstinence from alcohol and changes in cardiovascular risk factors, liver function tests and cancer-related growth factors: A prospective observational study. BMJ Open. 8(e020673)2018.PubMed/NCBI View Article : Google Scholar

20 

Lu W, Xu J, Taylor AW, Bewick BM, Fu Z, Wu N, Qian L and Yin P: Analysis of the alcohol drinking behavior and influencing factors among emerging adults and young adults: A cross-sectional study in Wuhan, China. BMC Public Health. 19(458)2019.PubMed/NCBI View Article : Google Scholar

21 

Saburova L, Keenan K, Bobrova N, Leon DA and Elbourne D: Alcohol and fatal life trajectories in Russia: Understanding narrative accounts of premature male death in the family. BMC Public Health. 11(481)2011.PubMed/NCBI View Article : Google Scholar

22 

Chiu WC, Huang YL, Chen YL, Peng HC, Liao WH, Chuang HL, Chen JR and Yang SC: Synbiotics reduce ethanol-induced hepatic steatosis and inflammation by improving intestinal permeability and microbiota in rats. Food Funct. 6:1692–1700. 2015.PubMed/NCBI View Article : Google Scholar

23 

Sivieri K, Morales ML, Adorno MA, Sakamoto IK, Saad SM and Rossi EA: Lactobacillus acidophilus CRL 1014 improved ‘gut health’ in the SHIME reactor. BMC Gastroenterol. 13(100)2013.PubMed/NCBI View Article : Google Scholar

24 

Ahrne S and Hagslatt ML: Effect of lactobacilli on paracellular permeability in the gut. Nutrients. 3:104–117. 2011.PubMed/NCBI View Article : Google Scholar

25 

van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ and Kleerebezem M: Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA. 108 (Suppl 1):S4562–S4569. 2011.PubMed/NCBI View Article : Google Scholar

26 

Susick RL Jr and Zannoni VG: Effect of ascorbic acid on the consequences of acute alcohol consumption in humans. Clin Pharmacol Ther. 41:502–509. 1987.PubMed/NCBI View Article : Google Scholar

27 

Xiaoqiang G, Wenjie L, Qiliang X, Hui D, Caiyun Z, Yanzhong C and Xianglin D: Vitamin C protective role for alcoholic liver disease in mice through regulating iron metabolism. Toxicol Ind Health. 27:341–348. 2011.PubMed/NCBI View Article : Google Scholar

28 

Bertola A, Mathews S, Ki SH, Wang H and Gao B: Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 8:627–637. 2013.PubMed/NCBI View Article : Google Scholar

29 

Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C and Neurath MF: Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2:2307–2311. 2007.PubMed/NCBI View Article : Google Scholar

30 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

31 

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al: QIIME allows analysis of high-throughput community sequencing data. Nature Methods. 7:335–336. 2010.PubMed/NCBI View Article : Google Scholar

32 

Bjørkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW and Valeur J: Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes. 10:663–675. 2019.PubMed/NCBI View Article : Google Scholar

33 

Kuprys PV, Cannon AR, Shieh J, Iftekhar N, Park SK, Eberhardt JM, Ding X and Choudhry MA: Alcohol decreases intestinal ratio of Lactobacillus to Enterobacteriaceae and induces hepatic immune tolerance in a murine model of DSS-colitis. Gut Microbes. 12:1–16. 2020.PubMed/NCBI View Article : Google Scholar

34 

Sarin SK, Pande A and Schnabl B: Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 70:260–272. 2019.PubMed/NCBI View Article : Google Scholar

35 

Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M and De Angelis M: The controversial role of human gut lachnospiraceae. Microorganisms. 8(573)2020.PubMed/NCBI View Article : Google Scholar

36 

Bode C and Bode JC: Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol. 17:575–592. 2003.PubMed/NCBI View Article : Google Scholar

37 

Szabo G: Gut-liver axis in alcoholic liver disease. Gastroenterology. 148:30–36. 2015.PubMed/NCBI View Article : Google Scholar

38 

Seo B, Jeon K, Moon S, Lee K, Kim WK, Jeong H, Cha KH, Lim MY, Kang W, Kweon MN, et al: Roseburia Spp. Abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host Microbe. 27:25–40.e6. 2020.PubMed/NCBI View Article : Google Scholar

39 

Roychowdhury S, Glueck B, Han Y, Mohammad MA and Cresci GAM: A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice. Nutrients. 11(97)2019.PubMed/NCBI View Article : Google Scholar

40 

Sönmez MF, Narin F, Akkuş D and Türkmen AB: Melatonin and vitamin C ameliorate alcohol-induced oxidative stress and eNOS expression in rat kidney. Ren Fail. 34:480–486. 2012.PubMed/NCBI View Article : Google Scholar

41 

Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M and Keshavarzian A: Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 43:163–172. 2009.PubMed/NCBI View Article : Google Scholar

42 

Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA and Schnabl B: Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 53:96–105. 2011.PubMed/NCBI View Article : Google Scholar

43 

Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO and van Sinderen D: Molecular dialogue between the human gut microbiota and the host: A Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci. 71:183–203. 2014.PubMed/NCBI View Article : Google Scholar

44 

Bernet MF, Brassart D, Neeser JR and Servin AL: Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 35:483–489. 1994.PubMed/NCBI View Article : Google Scholar

45 

Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J and Cantilena LR: Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 93:3704–3709. 1996.PubMed/NCBI View Article : Google Scholar

46 

Round JL and Mazmanian SK: Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. 107:12204–12209. 2010.PubMed/NCBI View Article : Google Scholar

47 

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN and Garrett WS: The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341:569–573. 2013.PubMed/NCBI View Article : Google Scholar

48 

Li Z, Li D, Tsun A and Li B: FOXP3+ regulatory T cells and their functional regulation. Cell Mol Immunol. 12:558–565. 2015.PubMed/NCBI View Article : Google Scholar

49 

Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller W and Rudensky AY: Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 34:566–578. 2011.PubMed/NCBI View Article : Google Scholar

50 

Cho YE and Song BJ: Pomegranate prevents binge alcohol-induced gut leakiness and hepatic inflammation by suppressing oxidative and nitrative stress. Redox Biol. 18:266–278. 2018.PubMed/NCBI View Article : Google Scholar

51 

Lei P, Zhao W, Pang B, Yang X, Li BL, Ren M and Shan YJ: Broccoli sprout extract alleviates alcohol-induced oxidative stress and endoplasmic reticulum stress in C57BL/6 mice. J Agric Food Chem. 66:5574–5580. 2018.PubMed/NCBI View Article : Google Scholar

52 

Faith M, Sukumaran A, Pulimood AB and Jacob M: How reliable an indicator of inflammation is myeloperoxidase activity? Clin Chim Acta. 396:23–25. 2008.PubMed/NCBI View Article : Google Scholar

53 

Olza J, Aguilera CM, Gil-Campos M, Leis R, Bueno G, Martínez-Jiménez MD, Valle M, Cañete R, Tojo R, Moreno LA and Gil A: Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children. Diabetes Care. 35:2373–2376. 2012.PubMed/NCBI View Article : Google Scholar

54 

Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L and Shao F: Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 514:187–192. 2014.PubMed/NCBI View Article : Google Scholar

55 

Wang H, Song X, Li M, Wang X, Tao Y, Xiya X, Liu H, Zhao Y, Chang D and Sha Q: The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia. Int Immunopharmacol. 83(106395)2020.PubMed/NCBI View Article : Google Scholar

56 

Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, et al: Chronic inflammation in the etiology of disease across the life span. Nat Med. 25:1822–1832. 2019.PubMed/NCBI View Article : Google Scholar

57 

Valenzuela R and Videla LA: Impact of the co-administration of N-3 fatty acids and olive oil components in preclinical nonalcoholic fatty liver disease models: A mechanistic view. Nutrients. 12(499)2020.PubMed/NCBI View Article : Google Scholar

58 

Wang W, Xu MJ, Cai Y, Zhou Z, Cao H, Mukhopadhyay P, Pacher P, Zheng S, Gonzalez FJ and Gao B: Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology. 66:108–123. 2017.PubMed/NCBI View Article : Google Scholar

59 

Echeverría F, Valenzuela R, Bustamante A, Álvarez D, Ortiz M, Espinosa A, Illesca P, Gonzalez-Mañan D and Videla LA: High-fat diet induces mouse liver steatosis with a concomitant decline in energy metabolism: Attenuation by eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation and the additive effects upon EPA and HT co-administration. Food Funct. 10:6170–6183. 2019.PubMed/NCBI View Article : Google Scholar

60 

Xie Z, Gao G, Wang H, Li E, Yuan Y, Xu J, Zhang Z, Wang P, Fu Y, Zeng H, et al: Dehydroabietic acid alleviates high fat diet-induced insulin resistance and hepatic steatosis through dual activation of PPAR-γ and PPAR-α. Biomed Pharmacother. 127(110155)2020.PubMed/NCBI View Article : Google Scholar

61 

Gyamfi D, Everitt HE, Tewfik I, Clemens DL and Patel VB: Hepatic mitochondrial dysfunction induced by fatty acids and ethanol. Free Radic Biol Med. 53:2131–2145. 2012.PubMed/NCBI View Article : Google Scholar

62 

Begriche K, Massart J, Robin MA, Borgne-Sanchez A and Fromenty B: Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. J Hepatol. 54:773–794. 2011.PubMed/NCBI View Article : Google Scholar

63 

Küper C, Beck FX and Neuhofer W: Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells. Am J Physiol Renal Physiol. 302:F38–F46. 2012.PubMed/NCBI View Article : Google Scholar

64 

Mardones M, Valenzuela R, Romanque P, Covarrubias N, Anghileri F, Fernández V, Videla LA and Tapia G: Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol. J Nutr Biochem. 23:1113–1120. 2012.PubMed/NCBI View Article : Google Scholar

65 

Valenzuela R, Illesca P, Echeverría F, Espinosa A, Rincón-Cervera MÁ, Ortiz M, Hernandez-Rodas MC, Valenzuela A and Videla LA: Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation. Food Funct. 8:1526–1537. 2017.PubMed/NCBI View Article : Google Scholar

66 

Sun J, Fu J, Zhong Y, Li L, Chen C, Wang X, Wang L, Hou Y, Wang H, Zhao R, et al: NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice. Food Chem Toxicol. 121:495–503. 2018.PubMed/NCBI View Article : Google Scholar

67 

Echeverría F, Valenzuela R, Bustamante A, Álvarez D, Ortiz M, Soto-Alarcon SA, Muñoz P, Corbari A and Videla LA: Attenuation of high-fat diet-induced rat liver oxidative stress and steatosis by combined hydroxytyrosol-(HT-) eicosapentaenoic acid supplementation mainly relies on HT. Oxid Med Cell Longev. 2018(5109503)2018.PubMed/NCBI View Article : Google Scholar

68 

Barrera C, Valenzuela R, Rincón M, Espinosa A, Echeverria F, Romero N, Gonzalez-Mañan D and Videla LA: Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration. Free Radic Biol Med. 126:313–321. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lu X and Wang F: <em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice. Exp Ther Med 22: 1005, 2021.
APA
Lu, X., & Wang, F. (2021). <em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice. Experimental and Therapeutic Medicine, 22, 1005. https://doi.org/10.3892/etm.2021.10438
MLA
Lu, X., Wang, F."<em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice". Experimental and Therapeutic Medicine 22.3 (2021): 1005.
Chicago
Lu, X., Wang, F."<em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice". Experimental and Therapeutic Medicine 22, no. 3 (2021): 1005. https://doi.org/10.3892/etm.2021.10438
Copy and paste a formatted citation
x
Spandidos Publications style
Lu X and Wang F: <em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice. Exp Ther Med 22: 1005, 2021.
APA
Lu, X., & Wang, F. (2021). <em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice. Experimental and Therapeutic Medicine, 22, 1005. https://doi.org/10.3892/etm.2021.10438
MLA
Lu, X., Wang, F."<em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice". Experimental and Therapeutic Medicine 22.3 (2021): 1005.
Chicago
Lu, X., Wang, F."<em>Lactobacillus acidophilus</em> and vitamin C attenuate ethanol‑induced intestinal and liver injury in mice". Experimental and Therapeutic Medicine 22, no. 3 (2021): 1005. https://doi.org/10.3892/etm.2021.10438
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team